Undiscovered Gems in Sweden to Explore October 2024
In This Article:
As global markets grapple with geopolitical tensions and economic shifts, the pan-European STOXX Europe 600 Index recently ended lower due to escalating conflicts in the Middle East, reflecting a cautious investor sentiment. In this climate of uncertainty, identifying promising small-cap stocks in Sweden can offer unique opportunities for growth as these companies often possess innovative potential and resilience that may not be immediately apparent to broader market participants.
Top 10 Undiscovered Gems With Strong Fundamentals In Sweden
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Softronic | NA | 3.58% | 7.41% | ★★★★★★ |
| Bahnhof | NA | 9.02% | 15.02% | ★★★★★★ |
| Firefly | NA | 16.04% | 32.29% | ★★★★★★ |
| AB Traction | NA | 5.38% | 5.19% | ★★★★★★ |
| AQ Group | 7.30% | 14.89% | 22.26% | ★★★★★★ |
| Svolder | NA | -22.68% | -24.17% | ★★★★★★ |
| Byggm?stare Anders J Ahlstr?m Holding | NA | 30.31% | -9.00% | ★★★★★★ |
| Creades | NA | -28.54% | -27.09% | ★★★★★★ |
| Linc | NA | 56.01% | 0.54% | ★★★★★★ |
| Solid F?rs?kringsaktiebolag | NA | 7.64% | 28.44% | ★★★★☆☆ |
Let's review some notable picks from our screened stocks.
Bonesupport Holding
Simply Wall St Value Rating: ★★★★★★
Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK20.41 billion.
Operations: Bonesupport generates revenue primarily from its pharmaceuticals segment, amounting to SEK735.16 million. The company's financial performance is highlighted by a focus on this core revenue stream.
Bonesupport Holding, a dynamic player in the biotech arena, recently turned profitable and is trading slightly below its fair value. The company showcases high-quality earnings with significant non-cash components. Recent highlights include a 31% forecasted annual earnings growth and no debt burden over the past five years. Notably, the SOLARIO study demonstrated that their products can drastically cut antibiotic use while maintaining infection control. However, recent insider selling may warrant attention from potential investors.
Cloetta
Simply Wall St Value Rating: ★★★★★☆
Overview: Cloetta AB (publ) is a confectionery company with a market capitalization of approximately SEK7.21 billion.
Operations: Cloetta generates revenue primarily from packaged branded goods and candy not packed in small bags, with sales figures of SEK6.24 billion and SEK2.22 billion, respectively.